Figure 2From: The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapyKaplan-Meier estimates of disease-free survival(DFS) and overall survival (OS) rates in relation to EZH2 expression. A. The 5-year DFS was significantly shorter in patients with high expression patients than in patients with low expression(p = 0.025). B. The 5-year OS was significantly shorter in patients with high expression patients than in patients with low expression (p = 0.032).Back to article page